Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, Torres J, Marques M, Habyan SA, Bijian K, Amant F, Witcher M, Behbod F, McCaffrey L, Alaoui-Jamali M, Giannakopoulos NV, Brackstone M, Postovit LM, Del Rincón SV, Miller WH Jr.

Cancer Res. 2019 Jan 18. doi: 10.1158/0008-5472.CAN-18-1602. [Epub ahead of print]

PMID:
30659022
2.

Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis.

Dahabieh MS, Ha Z, Di Pietro E, Nichol JN, Bolt AM, Goncalves C, Dupéré-Richer D, Pettersson F, Mann KK, Braverman NE, Del Rincón SV, Miller WH Jr.

Cell Death Differ. 2017 Nov;24(11):1912-1924. doi: 10.1038/cdd.2017.115. Epub 2017 Jul 21.

3.

H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Nichol JN, Dupéré-Richer D, Ezponda T, Licht JD, Miller WH Jr.

Adv Cancer Res. 2016;131:59-95. doi: 10.1016/bs.acr.2016.05.001. Epub 2016 Jun 17. Review.

4.

Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.

Dupéré-Richer D, Kinal M, Pettersson F, Emond A, Calvo-Vidal MN, Nichol JN, Guilbert C, Plourde D, Klein Oros K, Nielsen TH, Ezponda T, Licht JD, Johnson NA, Assouline S, Cerchietti L, Miller WH Jr, Mann KK.

Leuk Lymphoma. 2017 Jan;58(1):218-221. Epub 2016 May 17. No abstract available.

PMID:
27185211
5.

NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Nichol JN, Galbraith MD, Kleinman CL, Espinosa JM, Miller WH Jr.

Cell Rep. 2016 Mar 29;14(12):2938-49. doi: 10.1016/j.celrep.2016.02.074. Epub 2016 Mar 17.

6.

Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide.

Nichol JN, Garnier N, Miller WH Jr.

Best Pract Res Clin Haematol. 2014 Mar;27(1):19-31. doi: 10.1016/j.beha.2014.04.009. Epub 2014 May 2. Review.

PMID:
24907014
7.

The novel arsenical darinaparsin is transported by cystine importing systems.

Garnier N, Redstone GG, Dahabieh MS, Nichol JN, del Rincon SV, Gu Y, Bohle DS, Sun Y, Conklin DS, Mann KK, Miller WH Jr.

Mol Pharmacol. 2014 Apr;85(4):576-85. doi: 10.1124/mol.113.089433. Epub 2014 Jan 15.

PMID:
24431147
8.

Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.

McNamara S, Nichol JN, Wang H, Miller WH Jr.

Leukemia. 2010 Apr;24(4):729-39. doi: 10.1038/leu.2010.27. Epub 2010 Mar 4.

PMID:
20200558
9.

Expanding PML's functional repertoire through post-translational mechanisms.

Nichol JN, Petruccelli LA, Miller WH Jr.

Front Biosci (Landmark Ed). 2009 Jan 1;14:2293-306. Review.

PMID:
19273202
10.

ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.

Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH Jr.

Mol Cancer Res. 2004 Sep;2(9):523-31.

Supplemental Content

Loading ...
Support Center